Sei Investments CO Arcutis Biotherapeutics, Inc. Transaction History

Sei Investments CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $2.8 Million - $4.69 Million	273,599 New	273,599 $3.01 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $516,043 - $779,124	28,910 Added 20.09%	172,848 $3.3 Million
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $2.35 Million - $3.2 Million	143,938 New	143,938 $3.07 Million

196

130M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $797M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.